Puma Biotechnology Inc (PBYI) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PBYI Annual Balance Sheets →
The balance sheet data below highlights changes in Puma Biotechnology Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent36.19
Marketable Securities, Current SH65.35
Cash & Short-term Investments101.00
Accounts receivable26.33
Inventories8.69
Other Current Assets2.29
Prepaid Expense, Current AS3.41
Total Current Assets142.26
Equipment/Property/Plant Net0.12
Intangible Assets38.96
Other Assets, Noncurrent11.36
Total Assets192.70
Liabilities
Accounts Payable, Current AC8.17
Accrued Liabilities, Current AC38.38
Long-term Debt, Current Maturities LO11.28
Other Liabilities, Current1.91
Total Current Liabilities59.74
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent4.55
Total Liabilities64.28
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,415.97
Retained Earnings / Accumulated Deficit-1,287.53
Other Equity-0.03
Common Stockholder's Equity128.42
Total Stockholder's Equity128.42
Liabilities & Stockholder's Equity192.70
4 historic quarters locked

Sign in to unlock the full Puma Biotechnology Inc balance sheet history.

About Puma Biotechnology Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-026311

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.